| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 15.808 | 13.750 | 12.053 | 16.136 | 14.425 | 14.484 | 18.978 | 23.042 | 30.933 |
| Total Income - EUR | - | 15.808 | 13.750 | 12.053 | 16.136 | 14.427 | 14.485 | 18.978 | 23.042 | 30.933 |
| Total Expenses - EUR | - | 11.216 | 10.107 | 10.565 | 13.166 | 10.745 | 10.864 | 11.980 | 18.805 | 19.051 |
| Gross Profit/Loss - EUR | - | 4.592 | 3.642 | 1.488 | 2.970 | 3.681 | 3.620 | 6.998 | 4.236 | 11.881 |
| Net Profit/Loss - EUR | - | 4.276 | 3.505 | 1.368 | 2.808 | 3.541 | 3.475 | 6.808 | 4.006 | 10.972 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Onix Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 89 | 87 | 86 | 84 | 82 | 80 | 81 | 80 | 616 |
| Current Assets | - | 7.091 | 9.823 | 10.949 | 13.341 | 16.602 | 14.152 | 15.232 | 19.027 | 14.375 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.829 | 2.920 | 2.446 | 2.281 | 2.473 | 2.342 | 1.880 | 16.352 | 2.858 |
| Cash | - | 4.262 | 6.903 | 8.503 | 11.060 | 14.129 | 11.810 | 13.352 | 2.675 | 11.517 |
| Shareholders Funds | - | 5.411 | 8.824 | 10.030 | 12.644 | 15.945 | 13.487 | 14.132 | 18.095 | 13.670 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.769 | 1.086 | 1.005 | 781 | 739 | 745 | 1.181 | 1.012 | 1.321 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Onix Med Srl